FindTrial
Sign In

Analysis of the clinical effects of oxycodone in hysteroscopic patients

Analysis of the clinical effects of oxycodone in hysteroscopic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076707
Enrollment
Unknown
Registered
2023-10-17
Start date
2023-10-17
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Hydroxycodone group:Oxycodone + propofol for intravenous anesthesia
Sufentanil +group:Sufentanil + propofol used for intravenous anesthesia

Sponsors

Jinan Maternity and Child Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: American Association of Anesthesiologists (ASA) grade I-, 45 to 70 years, BMI 18.5 to 35 kg/m2, no history of psychotropic drugs, heart, liver, kidney, and blood tests were in the normal range.

Exclusion criteria

Exclusion criteria: Allergy to the study drug, combined with respiratory disease, suspected or confirmed history of alcohol and drug abuse, the patient withdrew from the trial.

Design outcomes

Primary

MeasureTime frame
Intraoperative incidence of respiratory depression;—

Secondary

MeasureTime frame
Lift the lower jaw, and assist in breathing + times;Malampati grading;hospital stay;Surgeon satisfaction;patient satisfaction;Steward's recovery score during resuscitation;vital signs;Adverse reactions;—

Countries

China

Contacts

Public ContactYaqiu Guo

Jinan Maternity and Child Care Hospital

guoyaqiu2013@163.com+86 180 5315 8617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026